142 related articles for article (PubMed ID: 3906415)
41. Immunologic characteristics of the leukocyte adherence inhibition assay in rheumatoid arthritis.
Tannenbaum H; Wild J
Clin Invest Med; 1983; 6(3):153-9. PubMed ID: 6360455
[TBL] [Abstract][Full Text] [Related]
42. Radioisotopic 51Cr-leukocyte adherence inhibition (LAI) assay. I. Demonstration of anti-tumor immunity in patients with breast carcinoma.
Tsang PH; Tangnavarad K; Lesnick G; Perloff M; Holland JF; Bekesi JG
J Immunol Methods; 1980; 36(2):119-35. PubMed ID: 7000908
[TBL] [Abstract][Full Text] [Related]
43. [Demonstration of cellular immunity by means of the leukocyte adherence inhibition (LAI) test in female breast neoplasms].
Fritze D; Ellinger K; Mayer D; Kaufmann M; Drings P; Döhnert G
Verh Dtsch Ges Inn Med; 1978; (84):577-9. PubMed ID: 742076
[No Abstract] [Full Text] [Related]
44. The humoral leukocyte adherence inhibition test in the investigation of lung cancer treated by surgery and radiotherapy.
Horváth M; Tóth L; Horváth A; Fekete B
Oncology; 1985; 42(4):229-31. PubMed ID: 3892402
[TBL] [Abstract][Full Text] [Related]
45. [Value of MS associated factors for test procedures in multiple sclerosis: 2. Angers' MS-induced substance in the LAI test].
Lehmitz R; Meyer U; Meyer-Rienecker HJ
Psychiatr Neurol Med Psychol (Leipz); 1983 Dec; 35(12):714-9. PubMed ID: 6366844
[TBL] [Abstract][Full Text] [Related]
46. The comparison of methods for determination of humoral and cell-mediated immunity in patients with breast cancer.
Nedbalová M; Trojan S; Dohnalová A; Jandová A
Electromagn Biol Med; 2009; 28(3):233-9. PubMed ID: 20001700
[TBL] [Abstract][Full Text] [Related]
47. Clinical value of the tube leukocyte adherence inhibition assay in diagnosis and prognosis of breast cancer.
Lopez MJ; O'Connor R; MacFarlane JK; Thomson DM
Surg Forum; 1977; 28():125-7. PubMed ID: 364712
[No Abstract] [Full Text] [Related]
48. [Predictive value of immunological studies in patients with maxillofacial malignancies. 1. Leukocyte adherence inhibition tests (LAI)].
Teuber S; Storch H; Gitt HA
Stomatol DDR; 1984 May; 34(5):266-72. PubMed ID: 6382696
[No Abstract] [Full Text] [Related]
49. Comparison of the hemocytometer and tube modifications of the leukocyte adherence inhibition assay -- II. Application of both modifications for detection of anti-tumor immunity in man.
Schimke R; Holán V; Sibl O; Hasek M; Ambrosius H
Neoplasma; 1981; 28(3):257-64. PubMed ID: 7027056
[TBL] [Abstract][Full Text] [Related]
50. [Further experience with the test of inhibition of leucocyte adherence (LAI) in the diagnosis of melanoblastomas of the choroid (author's transl)].
Kubát Z; Sachsová D; Jandová A; Heyberger K; Andrysek O
Sb Lek; 1979; 81(11-12):333-6. PubMed ID: 390683
[No Abstract] [Full Text] [Related]
51. Immunity to tumor-associated antigens in vasectomized men.
Anderson DJ; Alexander NJ; Fulgham DL; Vandenbark AA; Burger DR
J Natl Cancer Inst; 1982 Sep; 69(3):551-5. PubMed ID: 6180209
[TBL] [Abstract][Full Text] [Related]
52. [Changes in sensitivity of lymphocyte cholinergic receptors in patients with breast cancer].
Kharkevich DD; Polevaia EB
Eksp Onkol; 1988; 10(5):38-40. PubMed ID: 2905257
[TBL] [Abstract][Full Text] [Related]
53. Role of circulating antibodies in the humoral leukocyte adherence inhibition response of lung and breast cancer patients.
Kotlar HK; Sanner T
Cancer Lett; 1980 Nov; 11(1):11-9. PubMed ID: 7013972
[TBL] [Abstract][Full Text] [Related]
54. Leukocyte adherence inhibition by soluble tumor antigens in breast cancer patients.
Fujisawa T; Waldman SR; Yonemoto RH
Cancer; 1977 Feb; 39(2):506-13. PubMed ID: 65207
[TBL] [Abstract][Full Text] [Related]
55. The humoral leukocyte adherence inhibition in the discrimination among histologic types of lung cancer.
Horváth M; Fekete B; Forrai I
Oncology; 1983; 40(5):326-31. PubMed ID: 6194487
[TBL] [Abstract][Full Text] [Related]
56. [Attempts of checking up on the effects of treatment of gynecological cancer by means of the LAI test (author's transl)].
Novotná J; Kobilková J; Laurová L; Jandová A; Vinglerová H; Coupek K; Skoda V; Motycka K
Sb Lek; 1981; 83(11-12):326-31. PubMed ID: 7034144
[No Abstract] [Full Text] [Related]
57. [Postoperative results of the LAI test in patients with melanoblastoma of the choroid].
Kubát Z; Jandová A; Plichta B; Tomanová J; Andrysek O; Motycka K; Vinglerová H; Kobilková J
Sb Lek; 1982 Dec; 84(11-12):324-32. PubMed ID: 6761842
[No Abstract] [Full Text] [Related]
58. [The LAI test and the mammography picture].
Vejbora O; Smoranc P; Jandová A; Psenicka O; Kopecný J; Jandík P
Sb Lek; 1984 Jan; 86(1):10-4. PubMed ID: 6369505
[No Abstract] [Full Text] [Related]
59. Peripheral blood leukocyte adherence inhibition (LAI) reactivity before and during progressive growth of B77 tumor in rats.
Kalafut F; Klobusická M; Novotná L
Neoplasma; 1984; 31(5):507-13. PubMed ID: 6390225
[TBL] [Abstract][Full Text] [Related]
60. [Immunodiagnostic aspects of breast cancer. The phenomenon of leukocyte adherence inhibition].
Fritze D; Fritze J; Kaufmann M; Drings P
Minerva Med; 1978 Nov; 69(58):3963-7. PubMed ID: 740287
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
